Spindle cell hepatocellular carcinoma: A clinicopathologic and immunohistochemical analysis of 15 cases

Cancer

Volumn 77, Issue 1, 1996, Pages 51-57

  Maeda, Takashi ^a   Adachi, Eisuke ^a   Kajiyama, Kiyoshi ^a   Takenaka, Kenji ^a   Sugimachi, Keizo ^a   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Hepatocellular carcinoma; Immunohistochemistry; Prognosis; Sarcomatous change

Indexed keywords

ALPHA ACTIN; ALPHA FETOPROTEIN; CELL PROTEIN; CYTOKERATIN; DESMIN; PROTEIN HAM 56; PROTEIN KP 1; PROTEIN P53; PROTEIN S 100; UNCLASSIFIED DRUG; VIMENTIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; METASTASIS; PORTAL VEIN; PRIORITY JOURNAL; SPINDLE CELL CARCINOMA;

ADULT; AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0030043571     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960101)77:1<51::AID-CNCR10>3.0.CO;2-7     Document Type: Article

References (27)

1. Gal AA, Martin SE, Kernen JA, Patterson MJ. Esophageal carcinoma with prominent spindle cells. Cancer 1987; 60:2244-50.
2. Zarbo RJ, Crissman JD, Venkat H, Weiss MA. Spindle-cell carcinoma of the upper aerodigestive tract mucosa. An immunohistologic and ultrastructural study of 18 biphasic tumors and comparison with seven monophasic spindle-cell tumors. Am J Surg Pathol 1986;10:741-53.
3. Carcangiu ML, Steeper T, Zampi G, Rosai J. Anaplastic thyroid carcinoma: a study of 70 cases. Am J Surg Pathol 1985;83:135-58.
4. Barwick KW, LiVolsi VA. Malignant mixed Mullerian tumor of the uterus: a clinicopathologic assessment of 34 cases. Am J Surg Pathol 1979;3:125-35.
5. Humphrey PA, Scroggs MW, Roggli VL, Shelburne JD. Pulmonary carcinomas with a sarcomatoid element: an immunocytochemical and ultrastructural analysis. Hum Pathol 1988;19:155-65.
6. Matsui K, Kitagawa M. Spindle cell carcinoma of the lung. A clinicopathologic study of three cases. Cancer 1991;67:2361-7.
7. Ellis IO, Bell J, Ronan JE, Elston CW, Blarney RW. Immunohistochemical investigation of intermediate filament proteins and epithelial membrane antigen in spindle cell tumors of the breast. J Pathol 1988;154:157-65.
8. Suster S, Huszar M, Herczeg E, Bubis JJ. Adenosquamous carcinoma of the gallbladder with spindle cell features. A light microscopic and immunocytochemical study of a case. Histopathology 1987;11:209-14.
9. Robey-Cafferty SS, Grignon DJ, Ro JY, Cleary KR, Ayala AG, Ordonez NG, et al. Sarcomatoid carcinoma of the stomach. A report of three cases with immunohistochemical and ultrastructural observations. Cancer 1990;65:1601-6.
10. Guo KJ, Yamaguchi K, Enjoji M. Undifferentiated carcinoma of the gallbladder. A clinicopathologic, histochemical, and immunohistochemical study of 21 patients with a poor prognosis. Cancer 1988;61:1872-9.
11. Nishihara K, Tsuneyoshi M. Undifferentiated spindle cell carcinoma of the gallbladder: a clinicopathologic, immunohistochemical, and flow cytometric study of 11 cases. Hum Pathol 1993;24:1298-305.
12. Craig JR, Peters RL, Edmondson HA. Tumors of the liver and intrahepatic bile ducts. Atlas of tumor pathology, Fascicle 26, Series 2. Washington, DC: Armed Forces Institute of Pathology, 1989:179-80.
13. Ishak KG, Anthony PP, Sobin LH. Histological typing of tumours of the liver. 2nd ed. Geneva: World Health Organization, 1994.
14. Kakizoe S, Kojiro M, Nakashima T. Hepatocellular carcinoma with sarcomatous change: clinicopathologic and immunohistochemical studies of 14 autopsy cases. Cancer 1987;59:310-6.
15. Kojiro M, Sugihara S, Kakizoe S, Nakashioma O, Kiyomatsu K. Hepatocellular carcinoma with sarcomatous change; a special reference to the relationship with anticancer therapy. Cancer Chemother Pharmacol 1989;23:4-8.
16. Nagamine Y, Sasaki K, Kaku K, Takahashi M. Hepatic sarcoma associated with hepatoma. Acta Pathol Jpn 1978;28:645-51.
17. Shin P, Ohmi S, Sakurai M. Hepatocellular carcinoma combined with hepatic sarcoma. Acta Pathol Jpn 1981;31:815-24.
18. Haratake J, Horie A. An immunohistochemical study of sarcomatoid liver carcinomas. Cancer 1991;68:93-7.
19. Okuda K, Kondo Y, Nakano M, Kage M, Arakawa M, Kojiro M, et al. Hepatocellular carcinoma presenting with pyrexia and leukocytosis: report of five cases. Hepatology 1991;13:695-700.
20. Tsujimoto T, Aozasa K, Nakajima Y, Kariya M. Hepatocellular carcinoma with sarcomatous proliferation showing an unusual and wide-spread metastasis. Acta Pathol Jpn 1984;34:839-45.
21. Hsu SM, Raine L, Franger H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 181;75:816-21.
22. Chang WW, Agha FP, Morgan WS. Primary sarcoma of the liver in the adult. Cancer 1983;51:1510-7.
23. Kafiri G, Thomas DM, Shepherd NA, Krausz T, Lane DP, Hall PA. p53 Expression is common in malignant mesothelioma. Histopathology 1992;21:331-4.
24. Purdie CA, O'Grady J, Piris J, et al. p53 expression in colorectal tumors. Am J Pathol 1991;138:807-13.
25. Cohen C, DeRose PB. Immunohistochemical p53 in hepatocellular carcinoma and liver cell dysplasia. Mod Pathol 1994;7:536-9.
26. Miller C, Mohandas T, Wolf D, Prokocimer M, Rotter V, Koeffler HP. Human p53 gene localized to short arm of chromosome 17. Nature 1986;319:783-4.
27. Finlay CA, Hinds PW, Levine AJ. The p53 proto-oncogene can act as a suppressor of transformation. Cell 1989; 57:1083-93.